Type 2 & other diabetes

Risk of heart failure in elderly patients with atrial fibrillation and diabetes taking different oral anticoagulants: a nationwide cohort study

Cardiovasc DiabetolPublished Retrospective cohort study

Main finding · Newly diagnosed HFResult — go to the resultHazard ratio 0.80 95% CI 0.74–0.86

Authors' conclusion

This nationwide cohort study demonstrated that elderly patients with AF and DM taking NOACs had a lower risk of incident HF than those taking warfarin. Our findings suggested that NOACs may be the preferred oral anticoagulant treatment when considering the prevention of heart failure in this vulnerable population. Future research is warranted to elucidate causation and investigate the underlying mechanisms.

Study context

Population
Patients aged ≥ 65 years with atrial fibrillation (AF) and diabetes mellitus (DM) on NOAC or warfarin treatment between 2012 and 2019, followed up until 2020; Taiwanese nationwide claims data
Participants
24,835 patients
Exposure
NOACs vs warfarin
  • NOACn = 19,710
  • Warfarinn = 5,125reference
Outcome
Newly diagnosed HF
Methodological detailsnationwide, target trial emulation, propensity score-based fine stratification weighting
  • Nationwide
  • Target trial emulation
  • Propensity score-based fine stratification weighting

Main finding

As reported in the abstract

Hazard ratio

0.80

95% CI 0.74–0.86

P < 0.001

NOACvs Warfarin
HR 0.80 (95% CI 0.74–0.86); P < 0.001

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
HF by individual NOAC (subgroup analyses)Dabigatranvs Warfarin0.86 (0.80–0.93)P < 0.001
HF by individual NOAC (subgroup analyses)Rivaroxabanvs Warfarin0.80 (0.74–0.86)P < 0.001
HF by individual NOAC (subgroup analyses)Apixabanvs Warfarin0.78 (0.68–0.90)P < 0.001
HF by individual NOAC (subgroup analyses)Edoxabanvs Warfarin0.72 (0.60–0.86)P < 0.001

Heart failure (HF) by age, sex and medication possession ratio subgroups

Consistent regardless of age and sex subgroups; more prominent with high medication possession ratios

Original publication

Risk of heart failure in elderly patients with atrial fibrillation and diabetes taking different oral anticoagulants: a nationwide cohort study. Cardiovasc Diabetol. Published 6 January 2023. doi:10.1186/s12933-022-01688-1

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.